[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Immunology](https://durgical.com/en/immunology/) › [Transplant, tumors and immunotherapy](https://durgical.com/en/immunology/areas/transplant/) › How grafts are recognised: direct and indirect allorecognition

# How grafts are recognised: direct and indirect allorecognition

- Process

Recipient T cells react to donor MHC as it is, or to pieces of it shown by the recipient’s own cells; each route drives a different kind of rejection.

Updated Nov 15, 2026

## Key points

- Direct = donor MHC on donor APCs → strong early acute cellular rejection.
- Indirect = donor peptides on recipient MHC → alloantibodies and [chronic rejection](https://durgical.com/en/conditions/kidney-transplant-rejection/).
- Alloreactive T cells are very frequent because of TCR cross-reactivity.
- Minor antigens (H-Y) matter in HLA-matched transplants.

## What it is

Alloantigens are the donor molecules that differ from the recipient, above all the HLA (MHC) molecules, plus minor histocompatibility antigens and blood-group antigens. Recipient T cells recognise them in two main ways. In direct recognition, they react to intact donor MHC on donor antigen-presenting cells; in indirect recognition, recipient antigen-presenting cells process donor proteins and present them on self MHC. Direct recognition drives early acute cellular rejection, indirect recognition drives alloantibodies and chronic rejection.

## How to think about it

Direct recognition is meeting the stranger face to face: donor APCs show intact foreign MHC, and so many T cells cross-react that the early reaction is huge. Indirect recognition is studying the stranger's photograph: your own APCs show donor peptides, a normal-sized response that lasts as long as the graft and drives [antibodies](https://durgical.com/en/biochemistry/enzymes/immunoglobulins/). So early acute rejection is mostly direct, chronic rejection mostly indirect.

## Key facts

- Minor histocompatibility antigens are polymorphic non-HLA peptides; they explain GVHD even between HLA-identical siblings (for example male H-Y antigens seen by female donor T cells).
- ABO antigens on endothelium make ABO-incompatible solid-organ transplants risky without special preparation.
- C4d deposits in peritubular capillaries are a biopsy sign of antibody-mediated rejection.
- [Belatacept](https://durgical.com/en/pharmacology/belatacept/) blocks CD28 costimulation and is used to prevent kidney rejection.

## Step by step

- Donor dendritic cells (passenger [leukocytes](https://durgical.com/en/physiology/white-blood-cells-types-and-functions/)) leave the graft and reach recipient lymph nodes.
- Direct: recipient T cells see intact donor MHC–peptide; many cross-react, giving a strong early response.
- Indirect: recipient APCs take up shed donor MHC and proteins and present donor peptides on recipient MHC.
- Semi-direct: recipient APCs pick up intact donor MHC and present it on their own surface.
- With costimulation, CD8 T cells, Th1 cells and macrophages attack the graft.
- Indirect CD4 help lets B cells make donor-specific antibodies that injure graft endothelium with complement.

## Direct vs indirect allorecognition

| Feature | Direct | Indirect |
| --- | --- | --- |
| What T cells see | Intact donor MHC (with peptide) on donor APCs | Donor peptides on recipient MHC on recipient APCs |
| Frequency of responding T cells | Very high (roughly 1–10 % of T cells) | Like a normal response to a foreign protein |
| Timing | Early, while donor APCs persist | Persists for the life of the graft |
| Main outcome | Acute cellular (T-cell-mediated) rejection | Donor-specific antibodies, antibody-mediated and chronic rejection |

## Common traps

- **Only a few T cells can react to a graft, as with any antigen**: up to roughly 1–10 % of T cells react directly, because of TCR cross-reactivity.
- **Direct recognition drives chronic rejection**: direct fades as donor APCs die out; indirect sustains antibodies and chronic rejection.
- **HLA-identical siblings cannot cause GVHD**: minor histocompatibility antigens such as H-Y still differ.
- **Antibody-mediated rejection can be diagnosed without antibody tests**: it needs donor-specific antibodies plus biopsy signs such as C4d.

## Test yourself

Think of the answer, then tap the question to see it.

## Why is the early T-cell response against a graft so much bigger than against a typical microbe?

In direct recognition many T cells cross-react with intact foreign MHC, so a large fraction responds at once instead of a few rare clones.

## Years after a kidney transplant, donor-specific antibodies rise and the graft slowly fails. Which allorecognition pathway is responsible and why?

The indirect pathway; recipient APCs keep presenting donor peptides to helper T cells for the graft's lifetime, sustaining B-cell help.

## Why can GVHD occur between HLA-identical siblings?

Minor histocompatibility antigens, such as the male H-Y antigens, still differ and are recognised by donor T cells.

[Add to my cards (3)](https://durgical.app/estudiar/?add=/en/immunology/how-grafts-are-recognised-direct-and-indirect-allorecognition/)

## Elsewhere in DurgiPedia

- [Heart transplantation and cardiac devices](https://durgical.com/en/general-pathology/heart-transplantation-and-cardiac-devices/)

## Connections

## Related 7

- [Transplant rejection: hyperacute, acute, chronic](https://durgical.com/en/immunology/transplant-rejection-hyperacute-acute-chronic/)
- [HLA inheritance, typing and the crossmatch](https://durgical.com/en/immunology/hla-inheritance-typing-and-the-crossmatch/)
- [MHC/HLA class I and II](https://durgical.com/en/immunology/mhc-hla-class-i-and-ii/)
- [Graft-versus-host disease: the immunology](https://durgical.com/en/immunology/graft-versus-host-disease-the-immunology/)
- [Immunosuppressants by mechanism (classes)](https://durgical.com/en/immunology/immunosuppressants-by-mechanism/)
- [Antigen processing and presentation](https://durgical.com/en/immunology/antigen-processing-and-presentation/)
- [T-cell receptor signalling and the immune synapse (where drugs act)](https://durgical.com/en/immunology/t-cell-receptor-signalling-and-the-immune-synapse/)

## Related conditions 1

- [Kidney transplant rejection](https://durgical.com/en/conditions/kidney-transplant-rejection/)

[← All of immunology](https://durgical.com/en/immunology/)

Educational content on the immune system; not a treatment or individual vaccination guide and no substitute for a health professional's advice. No doses are given.

Sources: [Transplant rejection](https://medlineplus.gov/ency/article/000815.htm) (MedlinePlus, US National Library of Medicine, 2024); [Histocompatibility antigen test](https://medlineplus.gov/ency/article/003550.htm) (MedlinePlus, US National Library of Medicine, 2024).

## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake

Representative model, for educational purposes only.

---
Source: https://durgical.com/en/immunology/how-grafts-are-recognised-direct-and-indirect-allorecognition/
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/immunology/how-grafts-are-recognised-direct-and-indirect-allorecognition/
